Sharon Shacham Transaction History

Date Transaction Value Shares Traded Form
Feb 28 2022
SELL
Open market or private sale
$63,754 $10.24 p/Share
6,226
Feb 28 2022
BUY
Grant, award, or other acquisition
-
21,000
Feb 17 2022
SELL
Open market or private sale
$110,037 $12.12 p/Share
9,079
Feb 07 2022
SELL
Open market or private sale
$66,693 $9.86 p/Share
6,764
Mar 18 2021
SELL
Open market or private sale
$49,560 $12.39 p/Share
4,000
Feb 25 2021
BUY
Grant, award, or other acquisition
-
57,200
Feb 18 2021
SELL
Open market or private sale
$140,811 $14.83 p/Share
9,495
Feb 15 2021
BUY
Exercise of conversion of derivative security
-
21,800
Feb 11 2021
SELL
Open market or private sale
$102,448 $15.52 p/Share
6,601
Feb 05 2021
BUY
Exercise of conversion of derivative security
-
14,300

Also insider at

ACRV
Acrivon Therapeutics, Inc.
SS

Sharon Shacham

Chief Scientific Officer
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI